Contraindications for Bicarbonate (HCO3⁻) Infusion
Sodium bicarbonate infusion is absolutely contraindicated in patients losing chloride through vomiting or continuous gastrointestinal suction, and in those receiving diuretics that produce hypochloremic alkalosis 1.
Absolute Contraindications (FDA Drug Label)
The FDA-approved drug label explicitly identifies two absolute contraindications 1:
- Chloride loss from vomiting or continuous GI suction - These patients are already at risk for metabolic alkalosis from chloride depletion; bicarbonate would exacerbate this dangerous condition
- Concurrent use of diuretics causing hypochloremic alkalosis - Adding bicarbonate to patients already developing alkalosis from diuretic therapy creates severe risk of metabolic alkalosis
Relative Contraindications and High-Risk Situations
Clinical Scenarios Where Bicarbonate Should Be Avoided
Lactic acidosis with pH ≥ 7.15: The Surviving Sepsis Campaign guidelines explicitly recommend against bicarbonate use for improving hemodynamics or reducing vasopressor requirements in hypoperfusion-induced lactic acidemia when pH is 7.15 or higher 2. The evidence shows no benefit and potential harm in this common ICU scenario.
Cardiac arrest (routine use): Bicarbonate is not recommended for routine use during cardiac arrest 3. The evidence demonstrates no improvement in ROSC or survival, with multiple adverse effects including:
- Compromised coronary perfusion pressure through reduced systemic vascular resistance
- Paradoxical intracellular acidosis from excess CO2 production
- Inactivation of simultaneously administered catecholamines
- Extracellular alkalosis inhibiting oxygen release
Hypoventilation or inability to eliminate CO2: Bicarbonate generates CO2 that must be eliminated through ventilation 3, 4. In patients with:
- Inadequate mechanical ventilation
- Severe COPD or respiratory failure
- Mixed respiratory-metabolic acidosis with elevated PaCO2
The generated CO2 cannot be cleared, leading to worsening intracellular acidosis and central nervous system acidosis 3, 4.
Hypernatremia: Each dose of sodium bicarbonate delivers a substantial sodium load 1, 4. Avoid in patients with existing hypernatremia or those at risk (elderly, renal impairment).
Volume overload states: The hyperosmolar solution can worsen fluid overload in patients with:
- Congestive heart failure
- Pulmonary edema
- Oliguric renal failure
Neonates and vulnerable populations: Recent evidence shows bicarbonate causes progressive cerebral vasoconstriction and potential cerebral hypoperfusion in newborns 5. The Neonatal Resuscitation Program no longer recommends its use.
Specific Disease States Requiring Caution
Diabetic ketoacidosis (DKA): Guidelines recommend bicarbonate only when pH < 6.9-7.0 6. Routine use is not recommended due to:
- Risk of paradoxical CNS acidosis
- Delayed ketone clearance
- Hypokalemia
- Cerebral edema risk (especially in children)
Recent evidence suggests potential benefit in severe cases, but careful patient selection is critical 7.
Critical Adverse Effects to Monitor
When bicarbonate is used despite relative contraindications, monitor for 1, 8:
- Metabolic alkalosis with muscular twitching, irritability, tetany
- Hypokalemia - bicarbonate drives potassium intracellularly 3, 4
- Hypocalcemia (ionized calcium decreases) 8
- Hypernatremia and hyperosmolarity 3, 1
- Tissue necrosis from extravasation - hypertonic solutions cause chemical cellulitis; use central access when possible 9, 1
When Bicarbonate May Be Indicated
Despite these contraindications, bicarbonate has specific indications in:
- Severe metabolic acidosis with pH < 7.0-7.2 (individualized decision) 10
- Hyperkalemia (as temporizing measure)
- Tricyclic antidepressant overdose (sodium channel blockade)
- Aspirin toxicity (urinary alkalinization)
- Tumor lysis syndrome/rhabdomyolysis (controversial)
Key principle: The most recent large trial (BICARICU-2,2025) showed no mortality benefit from bicarbonate in severe metabolic acidemia with acute kidney injury, though it reduced need for renal replacement therapy 11. Another 2025 observational study suggested small mortality benefit, but emphasized the need for careful patient selection 12.
Bottom line: Do not use bicarbonate to "normalize" blood gas numbers. Treat the underlying cause of acidosis. Bicarbonate is a temporizing measure at best, with significant risks that often outweigh benefits outside of specific toxicologic emergencies.